医学
二甲双胍
内科学
2型糖尿病
糖尿病
单核苷酸多态性
2型糖尿病
基因型
等位基因
优势比
SNP公司
单倍型
作者
Peixian Chen,Yumin Cao,Yali Guo,Qi Xu,Xiaozhu Wang,Liuwei Zhang,Zhi-ke Liu,Dafang Chen,Shiyi Chen,Shenren Chen
出处
期刊:Pharmacogenetics and Genomics
[Ovid Technologies (Wolters Kluwer)]
日期:2021-09-20
标识
DOI:10.1097/fpc.0000000000000454
摘要
Metformin is the first-choice oral anti-hyperglycemic drug for type 2 diabetes mellitus (T2DM) patients. There are controversies about the association of SLC22A1 rs622342, which was not reported in the Chinese population, and ataxia-telangiectasia mutated (ATM) rs11212617 polymorphisms with metformin efficacy in T2DM. Our study was to investigate the effects of the two single nucleotide polymorphisms on the efficacy of metformin in T2DM of Han nationality in Chaoshan China. After enrollment, 82 newly diagnosed T2DM patients went on 2-month metformin monotherapy. According to BMI before treatment, the patients were divided into a normal weight group (≥18.5 and <25 kg/m2) and an overweight group (BMI ≥ 25 and <30 kg/m2). T-test, Pearson χ2 test, and regression analysis, which adjusted for age, BMI, sex, the dose of metformin, education, tea drink, smoking, and sweet, were used to evaluate the effects of rs622342 and rs11212617 on several variables, such as fasting plasma glucose (FPG). Compared with the AA or CC genotype, patients with AC genotype of rs622342 achieved greater reduction in Δ60FPG and Δ(60-30)FPG (P = 0.00820, 0.00089, respectively). For 11212617, the reduction in Δ30FPG and Δ60FPG was significantly different among patients with the AC genotype (P = 0.00026, 0.00820, respectively). Our results indicated that common variants of SLC22A1 rs622342 and ATM rs11212617 were associated with the efficacy of metformin in T2DM of Han nationality in Chaoshan China.
科研通智能强力驱动
Strongly Powered by AbleSci AI